Get it on Google Play

FDA Approves Idenix's (IDIX) TYZEKA for Chronic Hepatitis B

October 25, 2006 3:43 PM EDT Send to a Friend
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced FDA approval of TYZEKA as a new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login